I am bullish on CorMedix due to its strong financial turnaround, robust revenue growth, and unique market position. DefenCath, the only FDA-approved antimicrobial catheter lock solution in the US, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback